In 2022, the Genomic Cancer Panel and Profiling Market worldwide was assessed at USD 9.29 Bn. Analysts project it will advance to USD 18.69 Bn by 2031, at a CAGR of 8.38% spanning 2023 to 2031.
At its core, Genomic Cancer Panel and Profiling pertains to cutting-edge method for early cancer detection that studies tumour genetic features before symptoms manifest. Stakeholders across the healthcare landscape are growingly turning to these solutions to meet contemporary demands.
The market's upward path is propelled by growing healthcare spending, technological evolution, and the growing focus on personalized and precision-based approaches in healthcare.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region expected to deliver the strongest growth trajectory through the forecast period, propelled by demographic shifts and policy support.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Genomic Cancer Panel and Profiling Market Snapshot
Chapter 4. Global Genomic Cancer Panel and Profiling Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Tissue Testing Estimates & Trend Analysis
5.1. By Tissue Testing, & Market Share, 2020 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Tissue Testing:
5.2.1. Solid Tissue Testing
5.2.2. Liquid Tissue Testing
Chapter 6. Market Segmentation 2: By Cancer Panel Type Estimates & Trend Analysis
6.1. By Cancer Panel Type & Market Share, 2020 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Cancer Panel Type:
6.2.1. Single-Gene Panel
6.2.2. Multi-Gene Panel
Chapter 7. Market Segmentation 3: By Cancer Type Estimates & Trend Analysis
7.1. By Cancer Type & Market Share, 2020 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Cancer Type:
7.2.1. Lung Cancer
7.2.2. Breast Cancer
7.2.3. Colon Cancer
7.2.4. Prostate Cancer
7.2.5. Other Cancers
Chapter 8. Market Segmentation 4: By End-User Estimates & Trend Analysis
8.1. By End-User & Market Share, 2020 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By End-User:
8.2.1. Hospitals
8.2.2. Clinical and Diagnostic Laboratories
8.2.3. Research and Academic Institutes
8.2.4. Other End Users
Chapter 9. Market Segmentation 5: By Technology Estimates & Trend Analysis
9.1. By Technology & Market Share, 2020 & 2031
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Technology:
9.2.1. Next-Generation Sequencing (NGS)
9.2.2. Polymerase Chain Reaction (PCR)
9.2.3. Fluorescence In-Situ Hybridization (FISH)
9.2.4. Immunohistochemistry (IHC)
9.2.5. Others
Chapter 10. Market Segmentation 6: By Application Estimates & Trend Analysis
10.1. By Application & Market Share, 2020 & 2031
10.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Application:
10.2.1. Clinical
10.2.2. Research
Chapter 11. Genomic Cancer Panel and Profiling Market Segmentation 7: Regional Estimates & Trend Analysis
11.1. North America
11.1.1. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts By Tissue Testing, 2019-2031
11.1.2. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts By Cancer Panel Type, 2019-2031
11.1.3. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts By Cancer Type, 2019-2031
11.1.4. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts By End-User, 2019-2031
11.1.5. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts By Technology, 2019-2031
11.1.6. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts By Application, 2019-2031
11.1.7. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts by country, 2019-2031
11.2. Europe
11.2.1. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million By Tissue Testing, 2019-2031
11.2.2. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Panel Type, 2019-2031
11.2.3. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Type, 2019-2031
11.2.4. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million By End-User, 2019-2031
11.2.5. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million By Technology, 2019-2031
11.2.6. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million By Application, 2019-2031
11.2.7. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million by country, 2019-2031
11.3. Asia Pacific
11.3.1. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million By Tissue Testing, 2019-2031
11.3.2. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Panel Type, 2019-2031
11.3.3. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Type, 2019-2031
11.3.4. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million By End-User, 2019-2031
11.3.5. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million By Technology, 2019-2031
11.3.6. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million By Application, 2019-2031
11.3.7. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million by country, 2019-2031
11.4. Latin America
11.4.1. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million By Tissue Testing, (US$ Million) 2019-2031
11.4.2. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Panel Type, (US$ Million) 2019-2031
11.4.3. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Type, (US$ Million) 2019-2031
11.4.4. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million By End-User, (US$ Million) 2019-2031
11.4.5. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million By Technology, (US$ Million) 2019-2031
11.4.6. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million By Application, (US$ Million) 2019-2031
11.4.7. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million by country, 2019-2031
11.5. Middle East & Africa
11.5.1. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million By Tissue Testing, (US$ Million) 2019-2031
11.5.2. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Panel Type, (US$ Million) 2019-2031
11.5.3. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Type, (US$ Million) 2019-2031
11.5.4. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million By End-User, (US$ Million) 2019-2031
11.5.5. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million By Technology, (US$ Million) 2019-2031
11.5.6. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million By Application, (US$ Million) 2019-2031
11.5.7. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million by country, 2019-2031
Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles
12.2.1. Agilent Technologies, Inc.
12.2.2. ARUP Laboratories
12.2.3. Burning Rock DX
12.2.4. Caris Life Sciences
12.2.5. Thermo Fisher Scientific, Inc.
12.2.6. Danaher Corporation (Integrated DNA Technologies, Inc.)
12.2.7. Exact Sciences Corporation
12.2.8. F. Hoffmann-La Roche Ltd
12.2.9. Fulgent Genetics
12.2.10. Genecast Biotechnology Co., Ltd
12.2.11. Illumina, Inc.
12.2.12. Invitae Corporation